Microencapsulation as a tool for incorporating bioactive ingredients into food

Critical Reviews in Food Science and Nutrition

Volumn 50, Issue 10, 2010, Pages 951-968

  Kuang, S S ^a   Oliveira, Jorge C ^a   Crean, A M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Extrusion Spheronization; Fluidized Bed Coating; Matrix System; Microencapsulation; Reservoir System

Indexed keywords

EXTRUSION-SPHERONIZATION; FLUIDIZED-BED COATING; MATRIX SYSTEMS; MICROENCAPSULATION; RESERVOIR SYSTEM;

BIOCHEMISTRY; COATINGS; DRUG DELIVERY; DRUG INTERACTIONS; DRUG PRODUCTS; EXTRUSION; FLUIDIZATION; INDUSTRY; PACKAGING; PROFITABILITY; TECHNOLOGY;

ENCAPSULATION;

BIOLOGICAL PRODUCT; DRUG;

ARTICLE; CHEMISTRY; DIET SUPPLEMENTATION; DRUG FORMULATION; FOOD; FOOD HANDLING; METHODOLOGY; MICROCAPSULE;

BIOLOGICAL PRODUCTS; CAPSULES; DRUG COMPOUNDING; FOOD; FOOD TECHNOLOGY; FOOD, FORTIFIED; PHARMACEUTICAL PREPARATIONS;

EID: 78649622548     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408390903044222     Document Type: Article

References (89)

1. Agrawal, A.M., Howard, M.A., and Neau, S.H. (2004). Extruded and spheronized beads containing no microcrystalline cellulose: Influence of formulation and process variables. Pharmaceutical Development and Technology. 9(2): 197-217.
2. Agrawal, A.M., Howard, M.A., and Neau, S.H. (2006). Extruded and spheronized beads containing no microcrystalline cellulose: Influence of formulation and process variables. Pharmaceutical Development and Technology, 9(2): 197-217.
3. Anal, A.K. and Singh, H. (2007). Recent advances in microencapsulation of probiotics for industrial applications and targeted delivery. Trends in Food Science and Technology. 18: 240-251.
4. Baert, L. and Remon, J.P. (1993a). Influence of amount of granulation liquid on the drug release rate from pellets made by extrusion spheronization. International Journal of Pharmaceutics. 95: 135-141.
5. Baert, L., Remon, J.P., Elbers, J.A.C., and Van Bommel, E.M.G. (1993c). Comparison between a gravity feed extruder and a twin screw extruder. International Journal of Pharmaceutics. 99: 7-12.
6. Baert, L., Vermeersch, H., Remon, J.P., Smeyers-Verbeke, J., and Massart, D.L. (1993b). Study of parameters important in the spheronization process. International Journal of Pharamceutics. 96: 225-229.
7. Bando, H. and McGinity, J.W. (2006). Physicochemical properties of enteric films prepared from aqueous dispersions and organic solutions. International Journal of Pharmaceutics. 313: 43-48.
8. Basit, A.W., Newton, J.M., and Lacey, L.F. (1999). Formulation of ranitidine pellets by extrusion-pheronizationwithlittleornomicrocrystallinecellulose. Pharmaceutical Development and Technology 4: 499-505.
9. Bataille, B., Ligarski, K., Jacob, N., Thohas, C., and Duru, C. (1993). Study of the influence of spheronization and drying consitions on the physico-mechanical properties of neutral spheroids containing Aveicel PH 101 and lactose. Drug Development and Industrial Pharmacy 19: 653-671.
10. Bianchini, R., Bruni, G., Gazzaniga, A., and Vecchio, C. (1992). Influence of extrusion-spheronization processing on the physical properties of dIndobufen pellets containing pH adjusters. Drug Development and Industrial Pharmacy.18: 1485-1503.
11. Blanqué, D., Sternagel, H., Podczeck, F., and Newton, J.M. (1995). Some factors influencing the formation and in vitro drug release from matrix pellets prepared by extrusion/spheronization. International Journal of Pharmaceutics. 119: 203-211.
12. Boutell, S., Newton, J.M., Bloor, J.R., and Hayes, G. (2002). The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization. International Journal of Pharmaceutics. 238: 61-76.
13. Bruce,L.D.,Koleng,J.J.,andMcGinity,J.W.(2003).Theinfluenceofpolymeric subcoats and pellet formulation on the release of chlorpheniramine maleate from enteric coated pellets. Drug Development and Industrial Pharmacy. 29: 909-924.
14. Bruce, L.D., Petereit, H.-U., Beckert, T., and McGinity, J.W. (2003). Properties of enteric coated sodium valproate pellets. International Journal of Pharmaceutics. 264: 85-96.
15. Campbell, R.J. and Sackett, G.L. (1999). Film Coating. In: Pharmaceutical Unit Operations: Coating. pp. 55-176. Avis, K. E., Shukla, A. J., and Chang, R.-K., Eds., CRC Press, Florida.
16. Chariot, M., Frances, J., Lewis, G.A., Mathieu, D., Luu, R.P.T., and Stevens, H.N.E. (1987). A factorial approach to process variables of extrusionspheronization of wet powder masses. Drug Development and Industrial Pharmacy. 13(9): 1639-1649.
17. Christoph-Link, K. and Schlunder, E-U. (1997). Fluidized bed spray granulation Investigation of the coating process on a single sphere. Chemical Engineering and Processing. 36: 443-457.
18. Dewettinck, K. and Huyghebaert, A. (1999). Fluidized bed coating in food technology. Trends in Food Science & Technology. 10: 163-168.
19. Dupont, G., Flament M. P., Leterme, P., Farah, N., and Gayot, A. (2002). Developing a study method for producing 400 μm spheroids. International Journal of Pharmaceutics. 247: 159-165.
20. Felton, L.A. and McGinity, J.W. (1997). Influence of plasticizers on the adhesive propertiesof an acrylic resin copolymerto hydrophilicand hydrophobictablet compacts. International Journal of Pharmaceutics. 154(2): 167-178.
21. Felton, L.A. and McGinity, J.W. (1999).Adhesion of polymeric films to pharmaceutical solids. European Journal of Pharmaceutics and Biopharmaceutics. 47: 3-14.
22. Frenning, G., Tunon, A., and Alderborn, G. (2003). Modelling of drug release from coated granular pellets. Journal of Controlled Release. 92: 113-123.
23. Frisbee, S.E., Mehta, K., A., and McGinity, J.W. (2008). Processing factors that influence the in vitro and in vivo performance of film-coated drug delivery systems. Drug Delivery Technology. Retrieved online on 25 February, 2008. http://www.drugdeliverytech.com/cgi-bin/articles.cgi?idArticle=25
24. Gandhi, R., Kaul, C.L., and Panchagnula, R. (1999). Extrusion and spheronization in the development of oral controlled-release dosage forms. Pharmaceutical Science and Technology Today. 2: 160-170
25. Gharsallaoui, A., Roudaut, G., Chambin, O., Voilley, A., and Saurel, R. (2007). Applications of spray-drying in microencapsulation of food ingredients: An overview. Food Research International. 40: 1107-1121.
26. Ghosh, S.K. (2006). Functional coatings and microencapsulation: A general perspective. In Functional Coating. pp. 1-26. Ghosh, S. K., Ed., Wiley-VCH, Germany.
27. Gómez-Carracedo, A., Souto, C., Martínez-Pacheco, R., Concheiro, A., and Gómez-Amoza, J.L. (2007). Microstructural and drug release properties of oven-dried and of slowly or fast frozen freeze-dried MCC-Carbopol pellets. European Journal of Pharmaceutics and Biopharmaceutics.67: 236-245.
28. Gouin, S. (2004). Microencapsulation: Industrial appraisal of existing technologies and trends. Trends in Food Science & Technology. 15: 330-347.
29. Grassi, M., Grassi, G., Lapasin, R., and Colombo, I. (2007). Drug release from matrix systems. In: Understanding Drug Release and Absorption Mechanisms: A Physical and Mathematical Approach. pp. 371-479. CRC Press, Boca Raton, FL.
30. Gupta, V.K., Berkert, T.E., and Price, J.C. (2001). A novel pH and time based multi-unit potential colonic drug delivery system. I. Development. International Journal of Pharmaceutics. 213: 83-91.
31. Hasznos, L., Langer, I, and Gyarmathy, M. (1992). Some factors influencing pellets characteristics made by an extrusion/spheronization process Part I: Effects on size characteristics and moisture content decrease of pellets. Drug Development and Industrial Pharmacy. 18: 409-437.
32. Hayashi, T., Kanbe, H., Okada, M., Suzuki, M., Ikeda, Y., Onuki, Y., Kaneko, T., and Sonobe, T. (2005). Formulation study and drug release mechanism of a new theophylline sustained-release preparation. International Journal of Pharmaceutics. 304: 91-101.
33. Hellen, L., Yliruusi, J., and Kristoffersson, E. (1993). Process variables of instant granulator and spheronizer: II. Size and size distributions of pellets. International Journal of Pharmaceutics. 96: 205-216.
34. Heng, P.W.S. and Koo, O.M.Y. (2001). A study of the effects of the physic cal characteristics of microcrystalline cellulose on performance in extrusion spheronization. Pharmaceutical Research. 18: 480-487.
35. Huyghebaert, N., Vermeire, A., and Remon, J.P. (2005). In vitro evaluation of coating polymers for enteric coating and human ileal targeting. International Journal of Pharmaceutics. 298: 26-37.
36. Juppo, A.M., Hellén, L., Pullinen-Strander, V., Kalsta, K., Yliruusi, J., and Kristoffersson, E. (1997). Application of mercury porosimetry in evaluation of extrusion-spheronization process. European Journal of Pharmaceutics and Biopharmaceutics. 44: 205-214.
37. Kage, H., Abe, R., Hattanda, R., Zhou, T., Ogura, H., and Matsuno, Y. (2003). Effect of solid circulation rate on coating efficiency and agglomeration in circulating fluidized bed type coater. Powder Technology. 130: 203-210.
38. Kiortsis, S., Kachrimanis, K., Broussali, Th., and Malamataris, S. (2005). Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic components. European Journal of Pharmaceutics and Bio-pharmaceutics. 59: 73-83.
39. Kissel, T., Maretschek, S., Packhauser, C., Schnieders, J., and Seidel, N. (2006). Microencapsulation techniques for parenteral depot systems and their application in the pharmaceutical industry. In: Microencapsulation: Methods and Industrial Applications, 2nd Edition. pp. 99-118. Benita, S., Ed., CRC Press, Boca Raton, FL.
40. Kojima, M. and Nakagami, H. (2002). Development of controlled release matrix pellets by annealing with micronized water-insoluble or enteric polymers. Journal of Controlled Release. 82: 335-343.
41. Krogars, K., Heinämäki, J., Vesalahti, J., Marvola, M., Antikainen, O., and Yliruusi, J. (2000). Extrusion-spheronization of pH-sensitive polymeric matrix pellets for possible colonic drug delivery. International Journal of Pharmaceutics. 199: 187-194.
42. Ku, C.C., Joshi, Y.M., Bergum, J.S., and Jain, N.B. (1993). Bead manufacture by extrusion/spheronization a statistical design for process optimization. Drug Development and Industrial Pharmacy. 19: 1505-1519.
43. Kumar, M.N.V.R. and Kumar, N. (2001). Polymeric controlled drug-delivery systems: perspective issues and opportunities. Drug Development and Industrial Pharmacy. 27: 1-30.
44. Lecomte, F., Siepmann, J., Walther, M., MacRae, R.J., and Bodmeier, R. (2003). Blends of enteric and GIT-insoluble polymers used for film coating: physicochemical characterization and drug release patterns. Journal of Controlled Release. 89: 457-471.
45. Liew, C.V., Chua, S.M., and Heng, P.W.S. (2007). Elucidation of spheroid formation with and without the extrusion step. AAPS Pharm Sci Tech. 8:Article 10, E1-E12.
46. Lopes, Carla M., Lobo, J.M.S., Costa, P. and Pinto, J.F. (2006). Directly compressed mini matrix tablets containing ibuprofen: Preparation and evaluation of sustained release. Drug Development and Industrial Pharmacy. 32: 95-106.
47. MacRitchie, K.A., Newton, J.M., and Rowe, R.C. (2002). The evaluation of rheological properties of lactose/microcrystalline cellulose and water mistures by controlled stress rheometry and the relationship to the production of spherical pellets byextrusion/spheronization. European Journal of Pharmaceutical Sciences. 17: 43-50.
48. Manca, D. and Rovaglio, M. (2003). Modelling the controlled release of microencapsulated drugs: theory and experimental validation. Chemical Engineering Science. 58: 1337-1351.
49. Maronga, S. (1998). On the optimization of the fluidized bed particulate coating process. PhD Thesis, Royal Institute of Technology, Stockholm, Sweden.
50. Marvola, M., Nykänen, P., Rautio, S., Isonen, N., and Autere, A.-M. (1999). Enteric polymers as binders and coating materials in multiple-unit site-specific drug delivery systems. European Journal of Pharmaceutical Sciences. 7: 259-267.
51. Mehta, K.A., Kislalioglu, M.S., Phuapradit, W., Malick, A.W., and Shah, N.H. (2000). Effect of formulation and process variables on porosity parameters and release rates from a multi unit erosion matrix of a poorly soluble drug. Journal of Controlled Release. 63: 201-211.
52. Newton, J.M., Chapman, S.R., and Rowe, R.C. (1995). The influence of process variables on the preparation and properties of spherical granules by the process of extrusion and spheronization. International Journal of Pharmaceutics. 120: 101-109.
53. Nykänen, P., Krogars, K., Säkkinen, M., Heinämäki, J., Jürjensson, H., Veski, P., and Marvola, M. (1999). Organic acids as excipients in matrix granules for colon-specific drug delivery. International Journal of Pharmaceutics. 184: 251-261.
54. Obara, S. and McGinity, J.W. (1995). Influence of processing variables on the properties of free films prepared from aqueous polymeric dispersions by a spray technique. International Journal of Pharmaceutics. 126: 1-10.
55. Petereit, H.-U. and Weisbrod, W. (1998). Formulation and process considerations affecting the stability of solid dosage forms formulated with methacrylate copolymers. European Journal of Pharmaceutics and Biopharmaceutics. 47: 15-25.
56. Pharma Polymers (2001). Practical Course in Film Coating of Pharmaceutical Dosage Forms with Eudragit. Röhm Gmbh & Co. KG, Darmstardt, Germany.
57. Pothakamury, U.R. and Barbosa-Canovas, G.V. (1995). Fundamental aspects of controlled release in foods. Trends in Food Science & Technology. 6:397-406.
58. Rahman, N.-U. and Yuen, K.H. (2005). Eudragit NE40-Drug mixed coating system for controlling drug release of core pellets. Drug Development and Industrial Pharmacy. 31: 339-347.
59. Rahman, N.U., Yuen, K.H., and Woei, W.J. (2005). Gastrointestinal transit monitoring and absorption of controlled-release pellets of diltiazem. Pharmaceutical Development and Technology, 10(3): 371-379.
60. Siepmann, F., Muschert, S., Flament, M.P., Leterme, P., Gayot, A., and Siepmann, J. (2006). Controlled drug release from Gelucire-based matrix pellets: Experiment and theory. International Journal of Pharmaceutics. 317: 136-143.
61. Siepmann, F., Siepmann, J., Walther, M., MacRae, R., and Bodmeier, R. (2006). Aqueous HPMCAS coatings: Effects of formulation and processing parameters on drug release and mass transport mechanisms. European Journal of Pharmaceutics and Biopharmaceutics. 63: 262-269.
62. Siepmann, F., Wahle, C., Leclercq, B., Carlin, B., and Siepmann, J. (2008). pH-sensitive film coatings: Towards a better understanding and facilitated optimization. European Journal of Pharmaceutics and Biopharmaceutics. 68: 2-10.
63. Siepmann, J. and Göpferich, A. (2001). Mathematical modeling of bioerodible, polymeric drug delivery systems. Advanced Drug Delivery Reviews. 48: 229-247.
64. Singh, S.K., Reddy, I.K., and Khan, M.A. (1996). Optimization and characterization of controlled release pellets coated with an experimental latex: II. Cationic drug. International Journal of Pharmaceutics. 141: 179-195.
65. Sinha, V.R., Agrawal, M.K., and Kumria, R. (2005). Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization. Current Drug Delivery. 2: 1-8.
66. Sinha, V.R., Agrawal, M.K., Kumria, R., and Bhinge, J.R. (2007). Influence of operational variables on properties of piroxicam pellets prepared by extrusions pheronization: A technical note. AAPS PharmSciTech. 8: Article 20, E1-E5.
67. Sonaglio, D., Bataille, B., and Jacob, M. (1997). Effects of extrusion and formulationparameters ontheproductionofparacetamol-microcrystalline cellulose extrudates. Pharmaceutica Acta Helvetiae. 72: 69-74.
68. Sonaglio, D., Bataille, B., Ortigosa, C., and Jacob, M. (1995). Factorial design in the feasibility of producing Microcel MC 101 pellets by extrusion/ spheronization. International Journal of Pharmaceutics. 115: 53-60.
69. Sousa, J.J., Sousa, A., Podczeck, F., and Newton, J. M. (1996). Influence of process conditions on drug release from pellets. International Journal of Pharmaceutics. 144: 159-169.
70. Sousa, J.J., Sousa, A., Podczeck, F., and Newton, J.M. (2002). Factors influencing the physical characteristics of pellets obtained by extrusionspheronization. International Journal of Pharmaceutics. 232: 91-106.
71. Sparks, R.E., Jacods, I.C., and Mason, N.S. (1999). Microencapsulation. In: Pharmaceutical Unit Operations: Coating. pp. 177-222. Avis, K. E., Shukla, A. J., and Chang, R.-K., Eds., CRC Press, Boca Raton, Florida.
72. Sriamornsak, P., Nunthanid, J., Luangtana-anan, M., Puttipipatkhachorn, S. (2007). Alginate-based pellets prepared by extrusion/spheronization: A preliminary study on the effct of additive in granulating liquid. European Journal of Pharmaceutics and Biopharmaceutics. 67: 227-235.
73. Sudsakorn, K. and Turton, R. (2000). Nonuniformity of particle coating on a size distribution of particles in a fluidized bed coater. Powder Technology, 110(1-2, Special Issue: Sp. Iss. SI): 37-43.
74. Tewes, F., Boury, F., and Benoit, J.-P. (2006). Biodegradable Microspheres: Advances in Production Technology. In: Microencapsulation: Methods and Industrial Applications. pp. 1-44. Benita, S., Ed., CRC Press, Boca Raton, Florida.
75. Thoma, K. and Bechtold, K. (1999). Influence of aqueous coatings on the stability of enteric coated pellets and tablets. European Journal of Pharmaceutics and Biopharmaceutics. 47(1): 39-50.
76. Tunón, A., Börjesson, E., Frenning, G., and Alderborn, G. (2003). Drug release from reservoir pellets compacted with some excipients of different physical properties. European Journal of Pharmaceutical Sciences. 20: 469-479.
77. Turton, R., Bhatia, A., Hakim, H., Subramanian, G., and Norman, L. (2001). Research in particle coating and agglomeration at West Virginia University. Powder Technology. 117: 139-148.
78. Tzika, M., Alexandridou, S., and Kiparissides, C. (2003). Evaluation of the morphological and release characteristics of coated fertilizer granules produced in a Wurster fluidized bed. Powder Technology. 132: 16-24.
79. Varma, M. V. S., Kaushal, A. M., Garg, A., and Garg, S. (2004). Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems. American Journal of Drug Delivery.2: 43-57.
80. Varshosaz, J., Kennedy, R. A., and Gipps, E. M. (1997). Use of enteric polymers for production of microspheres by extrusion-spheronization. Pharmaceutica Acta Helvetiae. 72: 145-152.
81. Vervaet, C., Baert, L., Remon, J. P. (1995). Extrusion-spheronization: A literature review. International Journal of Pharameutics. 116: 131-146.
82. Wan, L. S. C., Heng, P. W. S., and Liew, C. V. (1993). Spheronization conditions on spheroid shape and size. International Journal of Pharmaceutics. 96: 5965.
83. Wang, C.-C., Zhang, G., Shah, N. H., Infeld, M. H., Malick, A. W., and McGinity, J. W. (1997). Influence of plasticizers on the mechanical properties of pellets containing Eudragit RS 30 D. International Journal of Pharmaceutics. 152: 153-163.
84. Werner, S. R. L., Jones, J. R., Paterson, A. H. J., Archer, R. H., and Pearce, D. L. (2007). Air-suspension coating in the food industry: Part II micro-level process approach. Powder Tecnology. 171: 34-45.
85. Wesseling, M. and Bodmeier, R. (1999). Drug release from beads coated with an aqueous colloidal ethylcellulose dispersion, Aquacoat or an organic ethylcellulose solution. European Journal of Pharmaceutics and Biopharmaceutics. 47: 33-38.
86. Williams III, R. O. and Liu, J. (2000). Influence of processing and curing conditions on beads coated with an aqueous dispersion of cellulose acetate phthalate. European Journal of Pharmaceutics Pharmaand Biopharmaceutics. 49: 243-252.
87. Wu, C. and McGinity. (2003). Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit RS 30D. Pharmaceutical Development and Technology. 8: 103-110.
88. Yang, S. T. and Ghebre-Sellassie, I. (1990). The effect of product bed temperature on the microstructure of Aquacoat-based controlled-release coatings. International Journal of Pharmaceutics. 60: 109-124.
89. Young, C. R., Dietzsch, C., Cerea, M., Farrell, T., Fegely, K. A., Rajabi-Siahboomi, A., and McGinity, J. W. (2005). Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer. International Journal of Pharmaceutics. 301: 112-120.